Tissue Dynamics

Tissue Dynamics is an Israeli biotechnology company founded in 2017 that is transforming drug and cosmetic development through its AI-powered organ-on-chip (OOC) platform. The company's Bionic Discovery Platform integrates advanced sensor technology, high-throughput robotic automation capable of forming and tracking over 20,000 human organoids in parallel, and the MechaniX AI software suite that reconstructs metabolic networks to identify novel targets and predict human-relevant toxicity with over 95% accuracy. Tissue Dynamics offers compound profiling, assay development, safety pharmacology, and drug development partnerships to pharmaceutical, nutraceutical, and cosmetic companies seeking human-relevant models that increase clinical success rates while reducing R&D costs.